| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Daniel J. Tancredi | Q43299345 |
| Irene Lenoir-Wijnkoop | Q63253367 | ||
| Max Nieuwdorp | Q88792521 | ||
| P2093 | author name string | Mary Ellen Sanders | |
| Glenn R Gibson | |||
| Bruno Pot | |||
| Bryon W Petschow | |||
| Paul Jacques | |||
| Seppo Salminen | |||
| Daniel J Merenstein | |||
| Christopher J Cifelli | |||
| P2860 | cites work | Whole grains, legumes, and the subsequent meal effect: implications for blood glucose control and the role of fermentation | Q21284961 |
| Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men | Q22250877 | ||
| Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review | Q26821790 | ||
| Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome | Q27006454 | ||
| Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials | Q27008982 | ||
| Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis | Q28266275 | ||
| RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet | Q29030043 | ||
| A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome | Q33409756 | ||
| A study of fructo oligosaccharides in the prevention of travellers' diarrhoea | Q33423514 | ||
| Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome | Q33441508 | ||
| A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea | Q33443603 | ||
| Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews | Q33451712 | ||
| Commensal bacteria at the interface of host metabolism and the immune system | Q33578547 | ||
| Innate immune recognition of the microbiota promotes host-microbial symbiosis | Q33945889 | ||
| New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? | Q34121906 | ||
| Prebiotic effects: metabolic and health benefits | Q34141652 | ||
| Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea | Q34159275 | ||
| Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis | Q34263143 | ||
| Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis | Q34325227 | ||
| Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications | Q34480156 | ||
| Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study | Q34571191 | ||
| Regulation of intestinal homeostasis and immunity with probiotic lactobacilli | Q34619461 | ||
| Recommendations for probiotic use-2011 update | Q34632974 | ||
| Prebiotics, immune function, infection and inflammation: a review of the evidence. | Q34836049 | ||
| The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review | Q34906850 | ||
| Assessing the quality of research | Q35113528 | ||
| A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women. | Q35335262 | ||
| Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults | Q37306249 | ||
| Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide. | Q37587557 | ||
| Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials | Q37935305 | ||
| Whole grain cereals: functional components and health benefits | Q37963745 | ||
| Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis | Q37964884 | ||
| Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain | Q38014819 | ||
| Rediscovering the core of public health | Q38058889 | ||
| Probiotics to prevent or treat excessive infant crying: systematic review and meta-analysis | Q38150106 | ||
| Health, agricultural, and economic effects of adoption of healthy diet recommendations | Q39186776 | ||
| Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial | Q42240129 | ||
| An analysis of online messages about probiotics | Q43008544 | ||
| The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study | Q44310521 | ||
| Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes. | Q44640179 | ||
| Association between yogurt, milk, and cheese consumption and common carotid artery intima-media thickness and cardiovascular disease risk factors in elderly women | Q44818711 | ||
| Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial | Q46080953 | ||
| Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study | Q46478436 | ||
| Oligofructose promotes satiety in healthy human: a pilot study | Q46845102 | ||
| Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women | Q46950960 | ||
| Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. | Q51353616 | ||
| Implausible results in human nutrition research. | Q54600212 | ||
| Dairy products and its association with incidence of cardiovascular disease: the Malmö diet and cancer cohort | Q57271604 | ||
| Dairy intake and coronary heart disease or stroke—A population-based cohort study | Q57910049 | ||
| The impact of context on evidence utilization: A framework for expert groups developing health policy recommendations | Q59160505 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | public health | Q189603 |
| probiotics | Q1816730 | ||
| P304 | page(s) | 19-29 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Probiotics and prebiotics: prospects for public health and nutritional recommendations | |
| P478 | volume | 1309 |
| Q58576463 | A Critical Appraisal of Probiotics for Mastitis Control |
| Q35342352 | A Novel Lactobacillus casei LP1 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Stimulator |
| Q27000702 | A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe |
| Q41755336 | Anaphylaxis to galacto-oligosaccharides--an evaluation in an atopic population in Singapore |
| Q36158206 | Beneficial microorganisms for honey bees: problems and progresses |
| Q47754400 | Detoxification of cancerogenic compounds by lactic acid bacteria strains |
| Q40044003 | Effects of Probiotics, Prebiotics, and Synbiotics on Human Health |
| Q40648131 | Evaluation of Aloe vera and synbiotic as antibiotic growth promoter substitutions on performance, gut morphology, immune responses and blood constitutes of broiler chickens |
| Q28241661 | Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic |
| Q58705730 | Fermented Foods as a Dietary Source of Live Organisms |
| Q42250683 | Fiber Patterns in Young Adults Living in Different Environments (USA, Spain, and Tunisia). Anthropometric and Lifestyle Characteristics |
| Q26776185 | Luminal Conversion and Immunoregulation by Probiotics |
| Q51276670 | Microencapsulated cells of Lactobacillus paracasei subsp. paracasei in biopolymer complex coacervates and their function in a yogurt matrix. |
| Q58620615 | Mitigation of Foodborne Illnesses by Probiotics |
| Q33466878 | Prebiotic Potential of a Maize-Based Soluble Fibre and Impact of Dose on the Human Gut Microbiota |
| Q26824061 | Probiotics in dietary guidelines and clinical recommendations outside the European Union |
| Q35363956 | Public health and budget impact of probiotics on common respiratory tract infections: a modelling study |
| Q104459094 | Receptor-targeted engineered probiotics mitigate lethal Listeria infection |
| Q33963171 | Removal of paralytic shellfish toxins by probiotic lactic acid bacteria |
| Q35605839 | Role of probiotics in reducing the risk of gestational diabetes. |
| Q35819780 | The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management |
| Q38873034 | The Potential Role of Yogurt in Weight Management and Prevention of Type 2 Diabetes |
| Q38331558 | The impact of early gut microbiota modulation on the risk of child disease: alert to accuracy in probiotic studies |
| Q36244829 | The prebiotics 3'Sialyllactose and 6'Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut-brain axis |
Search more.